Home Newsfeeds EF Hutton Maintains Buy on CEL-SCI, Lowers Price Target to $16

EF Hutton Maintains Buy on CEL-SCI, Lowers Price Target to $16

EF Hutton analyst Tim Moore maintains CEL-SCI (AMEX:CVM) with a Buy and lowers the price target from $17 to $16.

byBenzinga Newsdesk

December 29, 2022

1 minute read

EF Hutton analyst Tim Moore maintains CEL-SCI (AMEX:CVM) with a Buy and lowers the price target from $17 to $16.

Addiction Treatment Company, Indivior, Reports 12% YoY Growth For First Quarter Led By Sublocade Sales

By Nina Zdinjak

April 25, 10:04 AM

A global pharmaceutical company focused onÂ developing medicines to treat substance use disorders (SUD) andÂ seriousÂ mental illnesses,Â IndiviorÂ (NASDAQ:INDV) reported its financial…

INDV

Monolithic Power Systems Q3 Adj. EPS $3.53 Beats $3.50 Estimate, Sales $495.42M Beat $491.23M Estimate

By Michael Horton

October 27, 4:05 PM

Monolithic Power Systems (NASDAQ:MPWR) reported quarterly earnings of $3.53 per share which beat the analyst consensus estimate of $3.50 by 0.86 percent. This is a 71.36 percent increase over earnings of $2.06 per share

MPWR

Oppenheimer Maintains Outperform on Apellis Pharmaceuticals, Raises Price Target to $78

By Benzinga Newsdesk

August 18, 11:27 AM

Oppenheimer analyst Justin Kim maintains Apellis Pharmaceuticals (NASDAQ:APLS) with a Outperform and raises the price target from $68 to $78.

APLS

Trump Says Biden A ‘Manchurian Candidate,’ Promises Special Counsel Investigation If Reelected: ‘Look At All Of These Bribes’

By Navdeep Yadav

August 15, 11:37 PM

Donald Trump on Tuesday criticized President Joe Biden after being indicted for the fourth time in Georgia on Monday.

JOE

EF Hutton Maintains Buy on CEL-SCI, Lowers Price Target to $16

Related Posts

Addiction Treatment Company, Indivior, Reports 12% YoY Growth For First Quarter Led By Sublocade Sales

Monolithic Power Systems Q3 Adj. EPS $3.53 Beats $3.50 Estimate, Sales $495.42M Beat $491.23M Estimate

Oppenheimer Maintains Outperform on Apellis Pharmaceuticals, Raises Price Target to $78

Trump Says Biden A ‘Manchurian Candidate,’ Promises Special Counsel Investigation If Reelected: ‘Look At All Of These Bribes’